Therapy resistance in AML is mediated by cytoplasmic sequestration of the transcriptional repressor IRF2BP2

Mark J. Althoff(University of Colorado Anschutz Medical Campus), Craig T. Jordan(University of Colorado Anschutz Medical Campus)
bioRxiv (Cold Spring Harbor Laboratory)
May 24, 2025
Cited by 0


Related Papers